Baseline C-reactive protein (CRP) 2.72 (1.15
Wegovy EPAR Public Assessment Report
Gault VA, OHarte FP, Harriott P, Flatt PR
Persistent postgastrectomy hypoglycemia unawareness in patients with gastric cancer unveiled by a prospective study
While digestive enzymes while on GLP-1 therapy are sometimes considered, understanding the evidence, safety considerations, and proven management strategies is essential before adding supplements to your treatment regimen
The evidence consistently shows that patients who receive regular monitoring of metabolic markers, titration adjustments, and nutritional guidance alongside GLP-1 therapy achieve better outcomes and tolerate treatment more durably than those who access these medications without support